RECRUITING

Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatible with the needle insertion mechanism in the transrectal ultrasound (TRUS) probe. When inserted into the prostate, the fine needle PA probe will assess the histological information in its surrounding tissue without any tissue extraction. The needle probe has been tested in prostate tissue samples and whole human prostates ex vivo.

Official Title

Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe

Quick Facts

Study Start:2023-10-16
Study Completion:2025-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05965180

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years to 80 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 1) Planned prostate biopsy as part of routine clinical care
  2. * 2) \> 40 and \<80 years old
  1. * 1) Known history of bleeding disorders or
  2. * 2) Patients taking anticoagulants, no matter doses or washout time
  3. * 3) Known allergy to silicone material
  4. * 4) Unable to provide informed consent
  5. * 5) Either the surgeon or the patient do not think the patient will not be able to complete all parts of the study, the patient will be excluded
  6. * 6) Involved in other investigational studies.

Contacts and Locations

Study Contact

Cancer AnswerLine
CONTACT
1-800-865-1125
CancerAnswerLine@med.umich.edu

Principal Investigator

Guan Xu, Phd
PRINCIPAL_INVESTIGATOR
University of Michigan

Study Locations (Sites)

University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109
United States

Collaborators and Investigators

Sponsor: University of Michigan Rogel Cancer Center

  • Guan Xu, Phd, PRINCIPAL_INVESTIGATOR, University of Michigan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-16
Study Completion Date2025-10

Study Record Updates

Study Start Date2023-10-16
Study Completion Date2025-10

Terms related to this study

Keywords Provided by Researchers

  • Biopsy

Additional Relevant MeSH Terms

  • Prostate Cancer